American Association for Cancer Research
00085472can072536-sup-figure_s4.pdf (83.66 kB)

Supplementary Figure 4 from Integrated Profiling of Basal and Luminal Breast Cancers

Download (83.66 kB)
journal contribution
posted on 2023-03-30, 17:50 authored by José Adélaïde, Pascal Finetti, Ismahane Bekhouche, Laetitia Repellini, Jeannine Geneix, Fabrice Sircoulomb, Emmanuelle Charafe-Jauffret, Nathalie Cervera, Jérôme Desplans, Daniel Parzy, Eric Schoenmakers, Patrice Viens, Jocelyne Jacquemier, Daniel Birnbaum, François Bertucci, Max Chaffanet
Supplementary Figure 4 from Integrated Profiling of Basal and Luminal Breast Cancers



Basal and luminal are two molecular subtypes of breast cancer with opposite histoclinical features. We report a combined, high-resolution analysis of genome copy number and gene expression in primary basal and luminal breast cancers. First, we identified and compared genomic alterations in 45 basal and 48 luminal tumors by using 244K oligonucleotide array comparative genomic hybridization (aCGH). We found various genome gains and losses and rare high-level gene amplifications that may provide therapeutic targets. We show that gain of 10p is a new alteration in basal breast cancer and that a subregion of the 8p12 amplification is specific of luminal tumors. Rare high-level amplifications contained BCL2L2, CCNE, EGFR, FGFR2, IGF1R, NOTCH2, and PIK3CA. Potential gene breaks involved ETV6 and FLT3. Second, we analyzed both aCGH and gene expression profiles for 42 basal and 32 luminal breast cancers. The results support the existence of specific oncogenic pathways in basal and luminal breast cancers, involving several potential oncogenes and tumor suppressor genes (TSG). In basal tumors, 73 candidate oncogenes were identified in chromosome regions 1q21-23, 10p14, and 12p13 and 28 candidate TSG in regions 4q32-34 and 5q11-23. In luminal breast cancers, 33 potential oncogenes were identified in 1q21-23, 8p12-q21, 11q13, and 16p12-13 and 61 candidate TSG in 16q12-13, 16q22-24, and 17p13. HORMAD1 (P = 6.5 × 10−5) and ZNF703 (P = 7 × 10−4) were the most significant basal and luminal potential oncogenes, respectively. Finally, among 10p candidate oncogenes associated with basal subtype, we validated CDC123/C10orf7 protein as a basal marker. [Cancer Res 2007;67(24):11565–75]

Usage metrics

    Cancer Research





    Ref. manager